ATA260486A - Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Info

Publication number
ATA260486A
ATA260486A AT0260486A AT260486A ATA260486A AT A260486 A ATA260486 A AT A260486A AT 0260486 A AT0260486 A AT 0260486A AT 260486 A AT260486 A AT 260486A AT A260486 A ATA260486 A AT A260486A
Authority
AT
Austria
Prior art keywords
benzoxadiazol
dihydro
dimethyl
pharmaceutical compositions
active substance
Prior art date
Application number
AT0260486A
Other languages
English (en)
Other versions
AT402257B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA260486A publication Critical patent/ATA260486A/de
Application granted granted Critical
Publication of AT402257B publication Critical patent/AT402257B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0260486A 1985-10-01 1986-09-30 Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes AT402257B (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA260486A true ATA260486A (de) 1996-08-15
AT402257B AT402257B (de) 1997-03-25

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260486A AT402257B (de) 1985-10-01 1986-09-30 Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
DE60229123D1 (de) * 2001-02-20 2008-11-13 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
NL194822B (nl) 2002-12-02
HK392A (en) 1992-01-10
KR920008817B1 (ko) 1992-10-09
ES2002508A6 (es) 1988-08-16
DE3632201A1 (de) 1987-04-02
IL80182A (en) 1991-01-31
FR2589732A1 (fr) 1987-05-15
HUT44701A (en) 1988-04-28
NL8602370A (nl) 1987-05-04
IE59589B1 (en) 1994-03-09
FR2589732B1 (fr) 1989-07-13
DK170016B1 (da) 1995-05-01
NL194822C (nl) 2003-04-03
GR862457B (en) 1987-01-29
SG103391G (en) 1992-01-17
CA1298784C (en) 1992-04-14
DK464686D0 (da) 1986-09-29
DE3632201C2 (de) 1997-05-07
BE905516A (fr) 1987-03-30
DK464686A (da) 1987-04-02
AT402257B (de) 1997-03-25
IL80182A0 (en) 1986-12-31
PT83456B (pt) 1989-05-12
HU197201B (en) 1989-03-28
SE8604112L (sv) 1987-04-02
IE862565L (en) 1987-04-01
NZ217732A (en) 1990-07-26
SE8604112D0 (sv) 1986-09-29
PT83456A (en) 1986-10-01
LU86615A1 (fr) 1987-04-02
KR870003777A (ko) 1987-05-04
SE503222C2 (sv) 1996-04-22
CH669524A5 (de) 1989-03-31

Similar Documents

Publication Publication Date Title
JPS55301A (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
PT84496A (de) Kristalline wasserfreie 6-form von 2-]4-(2-furoyl)-(2-piperazin)-1-yl"-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung
AT382779B (de) Verfahren zur herstellung von festen pharmazeutischen dispersionszusammensetzungen mit rascher wirkstofffreisetzung
PH27356A (en) Annelated tetrahydropyridine acetic acid derivatives pharmaceutical composition containing said compound and method of use thereof
ATA106786A (de) Verfahren zur herstellung der neuen 7-amino-3propenylcephalosporansaeure sowie von estern und salzen derselben
ATA260486A (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes
ATA82386A (de) Verfahren zur herstellung von neuen 7beta-(2-(2amino-4-thiazolyl)-alkenoylamino)-3-cephem-4- carbonsaeureestern
DK291588A (da) Fremgangsmaade til fremstilling af ascorbinsyre-6-estere
FI884611A (fi) Menetelmä -/4-(1,1-dimetyylietyyli)fenyyli/-4-(hydroksidifenyylimetyyli)-1-piperidiinibutanolin farmaseuttisen koostumuksen valmistamiseksi
DE3673708D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATA327685A (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
ES8801543A1 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
DE59206868D1 (de) Pharmazeutische Zubereitungen mit einer speziellen Kristallmodifikation des 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsäure-isopropyl-(2-methoxyethyl)-esters
AT352728B (de) Verfahren zur herstellung von neuen tetrahydro- pyridin und piperidinderivaten und ihren saeureadditionssalzen
DE69114743D1 (de) Verfahren zur Herstellung von Fluormethyl-substituierten Dihydropyridin-carbodithioaten.
DK169185D0 (da) Dihydropyridin-3,5-dicarboxylsyreesterderivater, fremgangsmaade tilfremstilling heraf og farmaceutiske praeparater indeholdende disse
DK468385A (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
ATE122340T1 (de) Verfahren zur herstellung von (-)2-(2-(2- aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl - 3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4 dihydropyridin, und zwischenprodukt zu dessen herstellung.
ATA143787A (de) Verfahren zur herstellung von neuen derivaten der 4-phenyl 4-oxo 2-butensaeure
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
AT385990B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven eburnan-oxim-derivaten sowie von saeureadditions-salzen derselben
ATA223986A (de) Verfahren zur herstellung von neuen dihydropyridinderivaten
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
ATA902489A (de) Verfahren zur herstellung von chinolincarbonsäurederivaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time